(Q69398309)
Statements
Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma (English)
J H Edmonson
J E Krook
J F Hilton
G D Malkasian
L K Everson
J A Jefferies
1 September 1987